Anglais

This subject phenotype table contains subject ID, patient's cohort and age, living status during last assessment, gender, number of prior therapies, clinical benefit, tumor location and largest dimension, biopsy type, primary melanoma type, ipilimumab dose, drug treatment, response duration, serum lactate dehydrogenase, BRAF (GeneID: 673) or NRAS (GeneID: 4893) gene mutations, overall survival, and biopsy status before and after treatment.

5 Formulaires  
pht005208
Description

pht005208

Alias
UMLS CUI [1,1]
C3846158
De-identified Subject ID
Description

SUBJECT_ID

Type de données

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C2348585
Patient's cohort in current study
Description

Cohort

Type de données

string

Alias
UMLS CUI [1,1]
C0599755
UMLS CUI [1,2]
C0008972
Patient's age
Description

Age

Type de données

text

Unités de mesure
  • years
Alias
UMLS CUI [1,1]
C0001779
years
Alive during last assessment
Description

Alive

Type de données

text

Unités de mesure
  • Yes/No/Not Available
Alias
UMLS CUI [1,1]
C2584946
UMLS CUI [1,2]
C0679830
Gender of participant
Description

Sex

Type de données

text

Alias
UMLS CUI [1,1]
C0079399
Number of prior therapies (cytotoxic or IL-2)
Description

Priors

Type de données

text

Unités de mesure
  • 0,1,2,3,YES
Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0087111
UMLS CUI [1,4]
C0304497
UMLS CUI [1,5]
C0199975
0,1,2,3,YES
Long time clinical benefit
Description

Clinical_Benefit

Type de données

text

Alias
UMLS CUI [1,1]
C0443252
UMLS CUI [1,2]
C4684590
Location of tumor in study
Description

Site

Type de données

string

Alias
UMLS CUI [1,1]
C0450429
UMLS CUI [1,2]
C0027651
Largest dimension of tumor
Description

Largest Dimension (cm)

Type de données

text

Alias
UMLS CUI [1,1]
C2919402
Biopsy type
Description

Biopsy type

Type de données

string

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C4744818
Primary melanoma type
Description

Primary Melanoma type

Type de données

string

Alias
UMLS CUI [1,1]
C1306459
UMLS CUI [1,2]
C0025202
UMLS CUI [1,3]
C4744818
Ipilimumab dose
Description

Ipi_dosing

Type de données

text

Unités de mesure
  • mg/kg x no. dose
Alias
UMLS CUI [1,1]
C1367202
UMLS CUI [1,2]
C0178602
mg/kg x no. dose
Drug of treatment
Description

Drug

Type de données

string

Alias
UMLS CUI [1,1]
C0013227
Response duration in weeks
Description

Response duration (weeks)

Type de données

text

Alias
UMLS CUI [1,1]
C0871261
UMLS CUI [1,2]
C1948053
UMLS CUI [1,3]
C0439230
Serum lactate dehydrogenase
Description

LDH (normal less than 246)

Type de données

text

Unités de mesure
  • IU/L
Alias
UMLS CUI [1,1]
C0202113
IU/L
BRAF(GeneID: 673)/NRAS(GeneID: 4893) mutations
Description

BRAF/NRAS status

Type de données

string

Alias
UMLS CUI [1,1]
C0205309
UMLS CUI [1,2]
C0026882
UMLS CUI [1,3]
C0809246
UMLS CUI [1,4]
C0812241
Overall survival
Description

OS_yr

Type de données

text

Unités de mesure
  • years
Alias
UMLS CUI [1,1]
C4086681
years
Biopsy status before and after Ipilimumab treatment
Description

Biopsy pre or post ipi

Type de données

text

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C1367202
UMLS CUI [1,5]
C0087111
UMLS CUI [2,1]
C0005558
UMLS CUI [2,2]
C0449438
UMLS CUI [2,3]
C0231290
UMLS CUI [2,4]
C1367202
UMLS CUI [2,5]
C0087111
Retour au début de la page

Similar models

This subject phenotype table contains subject ID, patient's cohort and age, living status during last assessment, gender, number of prior therapies, clinical benefit, tumor location and largest dimension, biopsy type, primary melanoma type, ipilimumab dose, drug treatment, response duration, serum lactate dehydrogenase, BRAF (GeneID: 673) or NRAS (GeneID: 4893) gene mutations, overall survival, and biopsy status before and after treatment.

5 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht005208
C3846158 (UMLS CUI [1,1])
SUBJECT_ID
Item
De-identified Subject ID
string
C4684638 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
Cohort
Item
Patient's cohort in current study
string
C0599755 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
Age
Item
Patient's age
text
C0001779 (UMLS CUI [1,1])
Item
Alive during last assessment
text
C2584946 (UMLS CUI [1,1])
C0679830 (UMLS CUI [1,2])
Alive
Code List
Alive during last assessment
CL Item
Not available (Not available)
CL Item
Alive (Y)
Item
Gender of participant
text
C0079399 (UMLS CUI [1,1])
Sex
Code List
Gender of participant
CL Item
Female (F)
C0086287 (UMLS CUI [1,1])
CL Item
Male (M)
C0086582 (UMLS CUI [1,1])
Priors
Item
Number of prior therapies (cytotoxic or IL-2)
text
C0449788 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0304497 (UMLS CUI [1,4])
C0199975 (UMLS CUI [1,5])
Item
Long time clinical benefit
text
C0443252 (UMLS CUI [1,1])
C4684590 (UMLS CUI [1,2])
Clinical_Benefit
Code List
Long time clinical benefit
CL Item
Long time clinical benefits (LB)
CL Item
No long time clinical benefits (NB)
Site
Item
Location of tumor in study
string
C0450429 (UMLS CUI [1,1])
C0027651 (UMLS CUI [1,2])
Largest Dimension (cm)
Item
Largest dimension of tumor
text
C2919402 (UMLS CUI [1,1])
Biopsy type
Item
Biopsy type
string
C0005558 (UMLS CUI [1,1])
C4744818 (UMLS CUI [1,2])
Primary Melanoma type
Item
Primary melanoma type
string
C1306459 (UMLS CUI [1,1])
C0025202 (UMLS CUI [1,2])
C4744818 (UMLS CUI [1,3])
Ipi_dosing
Item
Ipilimumab dose
text
C1367202 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Drug
Item
Drug of treatment
string
C0013227 (UMLS CUI [1,1])
Response duration (weeks)
Item
Response duration in weeks
text
C0871261 (UMLS CUI [1,1])
C1948053 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
LDH (normal less than 246)
Item
Serum lactate dehydrogenase
text
C0202113 (UMLS CUI [1,1])
BRAF/NRAS status
Item
BRAF(GeneID: 673)/NRAS(GeneID: 4893) mutations
string
C0205309 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C0809246 (UMLS CUI [1,3])
C0812241 (UMLS CUI [1,4])
OS_yr
Item
Overall survival
text
C4086681 (UMLS CUI [1,1])
Item
Biopsy status before and after Ipilimumab treatment
text
C0005558 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C1367202 (UMLS CUI [1,4])
C0087111 (UMLS CUI [1,5])
C0005558 (UMLS CUI [2,1])
C0449438 (UMLS CUI [2,2])
C0231290 (UMLS CUI [2,3])
C1367202 (UMLS CUI [2,4])
C0087111 (UMLS CUI [2,5])
Biopsy pre or post ipi
Code List
Biopsy status before and after Ipilimumab treatment
CL Item
post Ipilimumab treatment (post)
CL Item
pre Ipilimumab treatment (pre)
Retour au début de la page